Venu Lagishetty
About Venu Lagishetty
Venu Lagishetty is a Senior Associate Scientist with extensive experience in using in vivo animal models to study chronic metabolic diseases. He has a strong background in biochemistry and microbiomics, having worked at various prestigious institutions including UCLA and Kite Pharma.
Work at Kite Pharma
Venu Lagishetty currently serves as a Senior Associate Scientist at Kite Pharma, a position he has held since 2022. In this role, he applies his extensive experience in scientific research to contribute to the development of innovative therapies. His work focuses on utilizing various biological systems and approaches to investigate complex biological processes.
Education and Expertise
Venu Lagishetty has a strong educational background in biochemistry and biological sciences. He completed his Ph.D. in Biochemistry at Osmania University from 2001 to 2006. He also holds a Postdoctoral Training in Biochemistry from UCLA, where he studied from 2007 to 2012. His expertise includes in vivo animal models, endocrine and animal physiology techniques, microbiomics, and nutrition.
Background in Research
Venu Lagishetty has a diverse research background, having worked in various capacities at the University of California, Los Angeles. He served as a Postdoctoral Fellow and Project Scientist from 2007 to 2021, focusing on microbiome research. His experience includes working as a Staff Research Associate from 2013 to 2015, where he contributed to various scientific projects.
Previous Experience at Instil Bio
Before joining Kite Pharma, Venu Lagishetty worked as a Scientist in Analytical Sciences at Instil Bio from 2021 to 2022. During his tenure in the Los Angeles Metropolitan Area, he utilized his skills in biochemistry and analytical techniques to support the company's research initiatives.
Research Techniques and Approaches
Venu Lagishetty specializes in a range of research techniques, including biochemistry, molecular biology, next-generation sequencing (NGS), and immunological techniques. His work often involves using in vivo animal models, particularly rats and mice, to study chronic metabolic diseases, demonstrating his adaptability in tackling new research areas.